Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II... see more

Recent & Breaking News (TSX:BCT)

BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board

GlobeNewswire February 23, 2022

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer

GlobeNewswire February 16, 2022

BriaCell Virtually Opens the Market

PR Newswire February 10, 2022

BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update

GlobeNewswire February 10, 2022

BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders

GlobeNewswire January 19, 2022

TMX Group Equity Financing Statistics - December 2021

PR Newswire January 11, 2022

BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq

GlobeNewswire December 29, 2021

BriaCell (TSXV:BCT) management to purchase 10 per cent of public market securities

Brieanna McCutcheon  December 17, 2021

BriaCell Announces Insiders' Intention to Purchase up to 10% of Public Market Securities

GlobeNewswire December 16, 2021

BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium®

GlobeNewswire December 9, 2021

BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer Study

GlobeNewswire November 18, 2021

BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences

GlobeNewswire November 12, 2021

BriaCell Adds Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board

GlobeNewswire November 5, 2021

BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors

GlobeNewswire November 2, 2021

BriaCell (TSXV:BCT) is advancing the fight with its immunotherapy

Brieanna McCutcheon  October 5, 2021

October is Breast Cancer Awareness Month - BriaCell is Advancing the Fight with its Immunotherapy

GlobeNewswire October 5, 2021

BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com

GlobeNewswire September 23, 2021

BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid

GlobeNewswire September 22, 2021

BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30

GlobeNewswire September 16, 2021

BriaCell (TSXV:BCT) announces securities buyback program

Brieanna McCutcheon  September 9, 2021